Mabol, Nora D.
HRN: 24-07-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
CEFUROXIME 1.5GM (VIAL)
11/11/2023
11/18/2023
IV
1.5 G
Every 8 Hours
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes